LNTH

Lantheus Holdings, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD111.16

+1.57 (+1.44%)

Rating:A-

Company Profile

CEO

Mary Anne Heino

IPO Date

2015-06-25

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

Market Metrics

Open

$109.80

Prev. Close

$109.58

Day Low

$109.00

Day High

$111.52

52W Low

$47.25

52W High

$111.52

Market Cap

$7.24B

Volume

0.14M

News SentimentBullish

Articles

Avg Positive

52.4%

Avg Negative

2.8%

Avg Neutral

44.6%

News Feed

Lantheus Announces the First and Only FDA Cleared AI-Enabled PSMA Digital Application, aPROMISE™, Strengthening Lantheus' Leadership in Prostate Cancer

Business Wire·7/29/2021·↑ positive

Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/28/2021·↓ negative

Lantheus Holdings (LNTH) Q2 Earnings and Revenues Beat Estimates